Mansour Alfayez

1.9k citations

54 papers · 775 indexed · h-index 15

Hematology top 2%
- Acute Myeloid Leukemia Research 24
- Hematopoietic Stem Cell Transplantation 7
- Chronic Myeloid Leukemia Treatments 7
Genetics top 10%
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4
Nephrology top 5%
Oncology
- CAR-T cell therapy research 6
Immunology
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 8
Molecular Biology
- Histone Deacetylase Inhibitors Research 5

Co-authors: Bertrand L. Jaber Naval Daver Ethan M. Balk Ioannis Koulouridis Hagop M. Kantarjian Tapan M. Kadia Thomas A Trikalinos Farhad Ravandi‐Kashani
Cited by: Hematology Genetics Nephrology
Journals: Journal of Clinical Oncology (3 papers)SHILAP Revista de lepidopterología (2 papers)Blood (14 papers)
Partner nations: United States Saudi Arabia United Kingdom

In The Last Decade

Mansour Alfayez

44 papers receiving 765 citations

Peers

Countries citing papers authored by Mansour Alfayez

Since Specialization

Citations

This map shows the geographic impact of Mansour Alfayez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mansour Alfayez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mansour Alfayez more than expected).

Fields of papers citing papers by Mansour Alfayez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mansour Alfayez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mansour Alfayez. The network helps show where Mansour Alfayez may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mansour Alfayez, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mansour Alfayez Line = papers co-authored together Mansour Alfayez links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LYSOZYME-INDUCED NEPHROPATHY IN CMML: A RARE BUT SIGNIFICANT COMPLICATION REQUIRING EARLY RECOGNITION AND INTERVENTION Hematology Transfusion and Cell Therapy ·Alfadil Haroon,Mohamed Kindawi,Ahmed Alotaibi,Ali Alahmari,Hazzaa Alzahrani,Mansour Alfayez,Syed Osman Ahmed	2025	0
2	Let It Grow: The Role of Growth Factors in Managing Chemotherapy-Induced Cytopenia Current Oncology ·Ruah Alyamany,Ahmed Alnughmush,Hazzaa Alzahrani,Mansour Alfayez	2024	0
3	First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families Blood ·Alfadil Haroon,Abdullah Al‐Jefri,Mohamed Jaradi,Ahmad S. Alotaibi,Mansour Alfayez,Hazza Alzahrani,Fahad Almohareb,Ali D Alahmari,Ayman Saad,Walid Rasheed,Fahad Alsharif,Naeem Chaudhri,Haitham Khogeer,Abdullah Alsuwaidan,Mahmoud Aljurf,Syed Osman Ahmed	2024	0
4	Single-Cell CD4 and CD8 T-Cell Secretome Profiling Reveals Temporal and Niche Differences in Acute Myeloid Leukemia Following Immune Checkpoint Blockade Therapy Cancer Research Communications ·Jessica L. Root,Poonam N. Desai,Christopher Ly,Bofei Wang,Fatima Zahra Jelloul,Jing Zhou,Sean Mackay,Mansour Alfayez,Jairo Matthews,Sherry Pierce,Patrick K. Reville,Naval Daver,Hussein A. Abbas	2024	5
5	Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice Clinical Lymphoma Myeloma & Leukemia ·Aamer Aleem,Naila Shaheen,Farjah Algahtani,Ahmed Jamal,Nora Alkhudair,Mashail Alghafis,Zafar Iqbal,Hajar Wan Zuki Siti,Abin Thomas,Bader Alahmari,Hind Salama,Giamal Gmati,Mohsen Alzahrani,Ayman Alhejazi,Mansour Alfayez,Abdullah M. Alrajhi,Mohammed Marei,Ahmed Alaskar	2024	0
6	ALL-462 Breaking Barriers: Pegaspargase Therapy in Adolescent and Young Adult Population Ages 14-55 Years Diagnosed With Acute Lymphoblastic Leukemia – Evidence From a Single-Center Study Clinical Lymphoma Myeloma & Leukemia ·Samar Alshammasi,Chokri Ben Lamine,Hajar A. AlHindi,L Taha,Ahmed Kotb Abdrabou,Mostafa Saleh,Momen Nassani,Sara Samarkandi,Hanan Alkhaldi,Mansour Alfayez,Ahmad S. Alotaibi,Ali Alahmari,Syed Osman Ali Ahmed,Ayman Saad,Amr Hanbali	2024	0
7	Azacitidine induced lung injury: report and contemporary discussion on diagnosis and management Frontiers in Oncology ·Ruah Alyamany,Ahmed Alnughmush,Malak Almutlaq,Mohammed Alyamany,Mansour Alfayez	2024	2
8	Cigarette smoke exposure accelerates AML progression in FLT3-ITD models Blood Advances ·Mary Figueroa,Huaxian Ma,Mansour Alfayez,Daniel E. Morales-Mantilla,Fei Wang,Yue Lu,Marcos R. Estecio,Katherine Y. King,Eugenie S. Kleinerman,Seyed Javad Moghaddam,Naval Daver,Michael Andreeff,Marina Konopleva,Courtney D. DiNardo,Joya Chandra	2023	2
9	Single-cell polyfunctional proteomics of CD4 cells from patients with AML predicts responses to anti–PD-1–based therapy Blood Advances ·Hussein A. Abbas,Zoe Alaniz,Sean Mackay,Matthew Cyr,Jing Zhou,Ghayas C. Issa,Mansour Alfayez,Jairo Matthews,Steven M. Kornblau,Elias Jabbour,Guillermo Garcia‐Manero,Marina Konopleva,Michael Andreeff,Naval Daver	2021	21
10	Upfront Alternative Donor Transplant versus Immunosuppressive Therapy in Patients with Severe Aplastic Anemia Who Lack a Fully HLA-Matched Related Donor: Systematic Review and Meta-Analysis of Retrospective Studies, on Behalf of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow Transplantation Transplantation and Cellular Therapy ·Hind Alotaibi,Mahmoud Aljurf,Régis de Latour,Mansour Alfayez,Andrea Bacigalupo,Riad El Fakih,Hubert Schrezenmeier,Syed Osman Ahmed,Éliane Gluckman,Shahid Iqbal,Britta Höchsmann,Constantijn J.M. Halkes,Josu de la Fuente,Nawal F Alshehry,Simone Cesaro,Jakob Passweg,Carlo Dufour,Antonio M. Risitano,John F. DiPersio,Ibraheem Motabi	2021	12
11	Safety and Efficacy of Azacitidine with Venetoclax for Newly Diagnosed Intensive Chemotherapy Ineligible, and Relapsed or Refractory Acute Myeloid Leukemia in Arab Population: A Single-Center, Retrospective Study Blood ·Mohammmad Alwadi,Jude Howaidi,Abdullah M. Alrajhi,Adel Alnakhli,Mohammed Marei,Imran K Tailor,Fouad Alnajjar,Syed Altaf,Mohammed S Alnoamani,Kamal Alzahrani,Hassan Alshehri,Ibraheem Motabi,Syed Ziauddin A. Zaidi,Nawal F Alshehry,Mansour Alfayez	2021	1
12	Outcome of patients with IDH1/2-mutated post–myeloproliferative neoplasm AML in the era of IDH inhibitors Blood Advances ·Helen T. Chifotides,Lucia Masárová,Mansour Alfayez,Naval Daver,Yesid Alvarado,Elias Jabbour,Marina Konopleva,Hagop M. Kantarjian,Keyur P. Patel,Courtney D. DiNardo,Srđan Verstovšek	2020	37
13	Posttransplantation cyclophosphamide improves transplantation outcomes in patients with AML/MDS who are treated with checkpoint inhibitors Cancer ·Betül Oran,Guillermo Garcia‐Manero,Rima M. Saliba,Mansour Alfayez,Gheath Alatrash,Stefan O. Ciurea,Elias Jabbour,Rohtesh S. Mehta,Uday Popat,Farhad Ravandi,Amin M. Alousi,Tapan M. Kadia,Marina Konopleva,Courtney D. DiNardo,Katy Rezvani,Elizabeth J. Shpall,Padmanee Sharma,Hagop M. Kantarjian,Richard E. Champlin,Naval Daver	2020	31
14	The Clinical impact of PTPN11 mutations in adults with acute myeloid leukemia Leukemia ·Mansour Alfayez,Ghayas C. Issa,Keyur P. Patel,Feng Wang,Xuemei Wang,Nicholas J. Short,Jörge E. Cortes,Tapan M. Kadia,Farhad Ravandi,Sherry Pierce,Rita Assi,Guillermo Garcia‐Manero,Courtney D. DiNardo,Naval Daver,Naveen Pemmaraju,Hagop M. Kantarjian,Gautam Borthakur	2020	43
15	An Intriguing Case of Eosinophilia with FIP1L1/PDGFRA Rearrangement Who Presented as Thrombotic Thrombocytopenic Purpura SHILAP Revista de lepidopterología ·Hassan Alshehri,Mohammad Alnomani,Mubarak S. AlGhamdi,Ibrahim Motabi,Imran K Tailor,Nawal F Alshehry,Mansour Alfayez,Abdul Rehman Zia Zaidi,Syed Altaf,Azizah F. AlSwayyed,Ammar AlSughayyer,Syed Ziauddin A. Zaidi	2019	0
16	Features of non-activation dendritic state and immune deficiency in blastic plasmacytoid dendritic cell neoplasm (BPDCN) Blood Cancer Journal ·Hannah C. Beird,Maliha Khan,Rui Wang,Mansour Alfayez,Tianyu Cai,Li Zhao,Joseph D. Khoury,P. Andrew Futreal,Marina Konopleva,Naveen Pemmaraju	2019	24
17	Ponatinib and Bosutinib Discontinuation in Chronic Myeloid Leukemia (CML): Single Center Experience Blood ·Mansour Alfayez,Hagop M. Kantarjian,Tapan M. Kadia,Guillermo Garcia‐Manero,Farhad Ravandi,Gautam Borthakur,Courtney D. DiNardo,Mary Beth Rios,Elias Jabbour,Jörge E. Cortes	2018	1
18	Validation of the 2017 European LeukemiaNet classification for acute myeloid leukemia with NPM1 and FLT3 ‐internal tandem duplication genotypes Cancer ·Prajwal Boddu,Tapan M. Kadia,Guillermo Garcia‐Manero,Jörge E. Cortes,Mansour Alfayez,Gautam Borthakur,Marina Konopleva,Elias Jabbour,Naval Daver,Courtney D. DiNardo,Kiran Naqvi,Musa Yılmaz,Nicholas J. Short,Sherry Pierce,Hagop M. Kantarjian,Farhad Ravandi	2018	37
19	Safety and Efficacy of Blinatumomab in Patients with Central Nervous System (CNS) Disease: A Single Institution Experience Blood ·Mansour Alfayez,Hagop M. Kantarjian,Nicholas J. Short,Rita Assi,Maria Khouri,Farhad Ravandi,Shilpa Paul,Caitlin R. Rausch,Patrice Nasnas,Gautam Borthakur,Courtney D. DiNardo,Tapan M. Kadia,Naval Daver,Guillermo Garcia‐Manero,Kiran Naqvi,Prithviraj Bose,Susan O’Brien,Jörge E. Cortes,Elias Jabbour	2018	11
20	Modifications in the basement membrane supramolecular structure of type IV collagen and laminin 5 organization facilitates skin derivative formation Biomedical Research-tokyo ·Mansour Alfayez	2010	1

About Mansour Alfayez

Mansour Alfayez is a scholar working on Hematology, Genetics and Oncology, having authored 54 papers that have together received 775 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (24 papers), Chronic Lymphocytic Leukemia Research (10 papers), Acute Lymphoblastic Leukemia research (8 papers), Hematopoietic Stem Cell Transplantation (7 papers), Chronic Myeloid Leukemia Treatments (7 papers), CAR-T cell therapy research (6 papers), Histone Deacetylase Inhibitors Research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (410 citations), Genetics (158 citations) and Nephrology (93 citations). Mansour Alfayez has collaborated with scholars based in United States, Saudi Arabia and United Kingdom. Frequent co-authors include Bertrand L. Jaber, Naval Daver, Ethan M. Balk, Ioannis Koulouridis, Hagop M. Kantarjian, Tapan M. Kadia, Thomas A Trikalinos, Farhad Ravandi‐Kashani, Gautam Borthakur and Marina Konopleva. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact